193 related articles for article (PubMed ID: 23359592)
1. Intestinal epithelial restitution after TcdB challenge and recovery from Clostridium difficile infection in mice with alanyl-glutamine treatment.
Rodrigues RS; Oliveira RA; Li Y; Zaja-Milatovic S; Costa LB; Braga Neto MB; Kolling GL; Lima AA; Guerrant RL; Warren CA
J Infect Dis; 2013 May; 207(10):1505-15. PubMed ID: 23359592
[TBL] [Abstract][Full Text] [Related]
2. Effects of adenosine A₂A receptor activation and alanyl-glutamine in Clostridium difficile toxin-induced ileitis in rabbits and cecitis in mice.
Warren CA; Calabrese GM; Li Y; Pawlowski SW; Figler RA; Rieger J; Ernst PB; Linden J; Guerrant RL
BMC Infect Dis; 2012 Jan; 12():13. PubMed ID: 22264229
[TBL] [Abstract][Full Text] [Related]
3. Plakoglobin and High-Mobility Group Box 1 Mediate Intestinal Epithelial Cell Apoptosis Induced by Clostridioides difficile TcdB.
Li Y; Xu W; Ren Y; Cheung HC; Huang P; Kaur G; Kuo CJ; McDonough SP; Fubini SL; Lipkin SM; Deng X; Chang YF; Huang L
mBio; 2022 Oct; 13(5):e0184922. PubMed ID: 36043787
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of alanyl-glutamine supplementation against nelfinavir-induced epithelial impairment in IEC-6 cells and in mouse intestinal mucosa.
Braga-Neto MB; Oliveira BM; Rodrigues RS; Noronha FJ; Leitao RF; Brito GA; Lima AA; Guerrant RL; Warren CA
Cancer Biol Ther; 2012 Dec; 13(14):1482-90. PubMed ID: 22986234
[TBL] [Abstract][Full Text] [Related]
5. Adenosine receptors differentially mediate enteric glial cell death induced by
Costa DVS; Shin JH; Goldbeck SM; Bolick DT; Mesquita FS; Loureiro AV; Rodrigues-Jesus MJ; Brito GAC; Warren CA
Front Immunol; 2022; 13():956326. PubMed ID: 36726986
[TBL] [Abstract][Full Text] [Related]
6.
Mileto SJ; Jardé T; Childress KO; Jensen JL; Rogers AP; Kerr G; Hutton ML; Sheedlo MJ; Bloch SC; Shupe JA; Horvay K; Flores T; Engel R; Wilkins S; McMurrick PJ; Lacy DB; Abud HE; Lyras D
Proc Natl Acad Sci U S A; 2020 Apr; 117(14):8064-8073. PubMed ID: 32198200
[TBL] [Abstract][Full Text] [Related]
7. Intrarectal instillation of Clostridium difficile toxin A triggers colonic inflammation and tissue damage: development of a novel and efficient mouse model of Clostridium difficile toxin exposure.
Hirota SA; Iablokov V; Tulk SE; Schenck LP; Becker H; Nguyen J; Al Bashir S; Dingle TC; Laing A; Liu J; Li Y; Bolstad J; Mulvey GL; Armstrong GD; MacNaughton WK; Muruve DA; MacDonald JA; Beck PL
Infect Immun; 2012 Dec; 80(12):4474-84. PubMed ID: 23045481
[TBL] [Abstract][Full Text] [Related]
8. Caspase and bid involvement in Clostridium difficile toxin A-induced apoptosis and modulation of toxin A effects by glutamine and alanyl-glutamine in vivo and in vitro.
Carneiro BA; Fujii J; Brito GA; Alcantara C; Oriá RB; Lima AA; Obrig T; Guerrant RL
Infect Immun; 2006 Jan; 74(1):81-7. PubMed ID: 16368960
[TBL] [Abstract][Full Text] [Related]
9. Vancomycin Treatment Alters Humoral Immunity and Intestinal Microbiota in an Aged Mouse Model of Clostridium difficile Infection.
van Opstal E; Kolling GL; Moore JH; Coquery CM; Wade NS; Loo WM; Bolick DT; Shin JH; Erickson LD; Warren CA
J Infect Dis; 2016 Jul; 214(1):130-9. PubMed ID: 26917573
[TBL] [Abstract][Full Text] [Related]
10. Disease Progression and Resolution in Rodent Models of Clostridium difficile Infection and Impact of Antitoxin Antibodies and Vancomycin.
Warn P; Thommes P; Sattar A; Corbett D; Flattery A; Zhang Z; Black T; Hernandez LD; Therien AG
Antimicrob Agents Chemother; 2016 Nov; 60(11):6471-6482. PubMed ID: 27527088
[TBL] [Abstract][Full Text] [Related]
11. Vancomycin treatment's association with delayed intestinal tissue injury, clostridial overgrowth, and recurrence of Clostridium difficile infection in mice.
Warren CA; van Opstal EJ; Riggins MS; Li Y; Moore JH; Kolling GL; Guerrant RL; Hoffman PS
Antimicrob Agents Chemother; 2013 Feb; 57(2):689-96. PubMed ID: 23147742
[TBL] [Abstract][Full Text] [Related]
12. Enteric glial cells are susceptible to Clostridium difficile toxin B.
Fettucciari K; Ponsini P; Gioè D; Macchioni L; Palumbo C; Antonelli E; Coaccioli S; Villanacci V; Corazzi L; Marconi P; Bassotti G
Cell Mol Life Sci; 2017 Apr; 74(8):1527-1551. PubMed ID: 27891552
[TBL] [Abstract][Full Text] [Related]
13. Subtyping analysis reveals new variants and accelerated evolution of Clostridioides difficile toxin B.
Shen E; Zhu K; Li D; Pan Z; Luo Y; Bian Q; He L; Song X; Zhen Y; Jin D; Tao L
Commun Biol; 2020 Jul; 3(1):347. PubMed ID: 32620855
[TBL] [Abstract][Full Text] [Related]
14. Glutamine and alanyl-glutamine increase RhoA expression and reduce Clostridium difficile toxin-a-induced intestinal epithelial cell damage.
Santos AA; Braga-Neto MB; Oliveira MR; Freire RS; Barros EB; Santiago TM; Rebelo LM; Mermelstein C; Warren CA; Guerrant RL; Brito GA
Biomed Res Int; 2013; 2013():152052. PubMed ID: 23484083
[TBL] [Abstract][Full Text] [Related]
15. Identification of the role of toxin B in the virulence of Clostridioides difficile based on integrated bioinformatics analyses.
Gao Y; Gao W; Cheng J; Ma L; Su J
Int Microbiol; 2020 Nov; 23(4):575-587. PubMed ID: 32388701
[TBL] [Abstract][Full Text] [Related]
16. Transforming Growth Factor β1/SMAD Signaling Pathway Activation Protects the Intestinal Epithelium from Clostridium difficile Toxin A-Induced Damage.
Tinoco-Veras CM; Santos AAQA; Stipursky J; Meloni M; Araujo APB; Foschetti DA; López-Ureña D; Quesada-Gómez C; Leitão RFC; Gomes FCA; Brito GAC
Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28784928
[No Abstract] [Full Text] [Related]
17. The role of toxins in Clostridium difficile infection.
Chandrasekaran R; Lacy DB
FEMS Microbiol Rev; 2017 Nov; 41(6):723-750. PubMed ID: 29048477
[TBL] [Abstract][Full Text] [Related]
18. Clostridium difficile toxin A induces intestinal epithelial cell apoptosis and damage: role of Gln and Ala-Gln in toxin A effects.
Brito GA; Carneiro-Filho B; Oriá RB; Destura RV; Lima AA; Guerrant RL
Dig Dis Sci; 2005 Jul; 50(7):1271-8. PubMed ID: 16047471
[TBL] [Abstract][Full Text] [Related]
19. Clostridium difficile toxin-induced inflammation and intestinal injury are mediated by the inflammasome.
Ng J; Hirota SA; Gross O; Li Y; Ulke-Lemee A; Potentier MS; Schenck LP; Vilaysane A; Seamone ME; Feng H; Armstrong GD; Tschopp J; Macdonald JA; Muruve DA; Beck PL
Gastroenterology; 2010 Aug; 139(2):542-52, 552.e1-3. PubMed ID: 20398664
[TBL] [Abstract][Full Text] [Related]
20. Clostridium difficile toxins A and B can alter epithelial permeability and promote bacterial paracellular migration through HT-29 enterocytes.
Feltis BA; Wiesner SM; Kim AS; Erlandsen SL; Lyerly DL; Wilkins TD; Wells CL
Shock; 2000 Dec; 14(6):629-34. PubMed ID: 11131913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
